On Air Now

Listen

Listen Live Now » 95.5 FM Wausau, WI

Weather

Current Conditions(Wausau,WI 54403)

More Weather »
61° Feels Like: 61°
Wind: W 8 mph Past 24 hrs - Precip: 0.01”
Current Radar for Zip

Today

Isolated Thunderstorms 79°

Tonight

Mostly Clear 56°

Tomorrow

Scattered Thunderstorms 80°

Alerts

Breaking News

BREAKING NEWS / URGENT: The State Supreme Court upholds Act 10, Voter ID, and the state's domestic partnership registry

MADISON, Wis (WSAU)  - The Wisconsin State Supreme Court upheld Act 10, the state law that limits the collective bargaining rights of state employees. The law from three years ago sparked protests at the state capital and led to the recall attempt against Governor Scott Walker. The court's ruling in favor of Act 10 was 5-2. Justice Michael Gableman wrote the lead opinion, which was also signed by Justices David Prosser, Pat Roggensack and Annette Ziegler. Justice Patrick Crooks concurre...

Read More »

Allergan to pay $350 million for SkinMedica skin products co

(Reuters) - Allergan Inc, maker of anti-wrinkle drug Botox, on Friday said it would pay $350 million to acquire privately held SkinMedica Inc and its array of topical products to improve the appearance of the skin.

Allergan, whose facial aesthetics business includes the widely used Juvederm facial filler, said it intends to complete the purchase this year and operate SkinMedica as a separate business.

Allergan said it would also pay SkinMedica an additional $25 million contingent on the acquired products hitting sales targets. The deal does not include SkinMedica's Colorescience aesthetic make-up line, Allergan said.

SkinMedica sells both prescription and non-prescription products. Its primary prescription product is Vaniqa cream, the only U.S. approved prescription product for reduction of unwanted facial hair in women.

Allergan shares rose 1 percent to $88.84 in morning trading on the New York Stock Exhhange, amid slight declines for the broad stock market.

(Reporting By Ransdell Pierson; Editing by Gerald E. McCormick and Theodore d'Afflisio)

Comments